Characterization of Released N-linked Glycans in Biosimilar mAb Drug Products Using the Xevo™ G3 QTof
Applications | 2023 | WatersInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
IndustriesPharma & Biopharma
ManufacturerWaters
Key wordsglycan, biosimilar, rfms, elevated, released, glycans, innovator, renflexis, fragment, energy, premier, remicade, acquity, mab, profiles, infliximab, monosaccharide, products, spectra, mse, glycovariation, detail, streamlined, drug, hilic, linked, ion, labeled, structural, fragmentation, sufficient, confirm, obtainable, uplc, reprocessed, originator, using, differences, greater, meet, abundance, characterization, linkages, appropriate, glycoworks, enzymatically, rapifluor, also, compiled, bsm
Similar PDF
Comprehensive Biosimilar Comparability Assessment via Intact and Subunit RP-MS and IEX-UV-MS Using the Xevo™ G3 QTof System
2022|Waters|Applications
Application Note Comprehensive Biosimilar Comparability Assessment via Intact and Subunit RP-MS and IEX-UV-MS Using the Xevo™ G3 QTof System Samantha Ippoliti, Owen Cornwell, Lisa Reid, Ying Qing Yu, Emma Harry, Mark Towers Waters Corporation Abstract With the increasing prevalence of…
Key words
subunit, subunitcomparability, comparabilityiex, iexbiosimilar, biosimilarintact, intactassessment, assessmentvia, viacomprehensive, comprehensiveusing, usingcarboxypeptidase, carboxypeptidasemab, mabterminal, terminallysine, lysinevariant, variantvariants
Improving Chromatographic Separations Of Biopharmaceuticals With MaxPeak High Performance Surfaces (HPS) Technology
2023|Waters|Brochures and specifications
Improving Chromatographic Separations Of Biopharmaceuticals With MaxPeak High Performance Surfaces (HPS) Technology Analytical Solutions Using MaxPeak High Performance Surfaces (HPS) Technology for Biopharmaceutical Therapeutics Biopharmaceutical therapeutics have consistently been the fastest growing segment within the pharmaceutical space and require advances…
Key words
premier, premieracquity, acquityglycan, glycanmaxpeak, maxpeaknucleotide, nucleotideculture, culturehps, hpspeptide, peptideintact, intactsystem, systembioaccord, bioaccordcolumn, columnprotein, proteinread, readglycans
Applying Peptide Mapping and Multi- Attribute Method (MAM) Workflow for Biosimilar mAb Drug Products Comparison on the Xevo™ G3 QTof Platform
2022|Waters|Applications
Application Note Applying Peptide Mapping and MultiAttribute Method (MAM) Workflow for Biosimilar mAb Drug Products Comparison on the Xevo™ G3 QTof Platform Kellen DeLaney, Samantha Ippoliti, Lisa Reid, Owen Cornwell, Ying Qing Yu, Emma Harry, Mark Towers Waters Corporation Abstract…
Key words
biosimilar, biosimilarmam, mamattribute, attributemapping, mappingpeptide, peptidemab, mabapplying, applyingdrug, drugworkflow, workflowmulti, multiproducts, productsmethod, methodattributes, attributesinnovator, innovatorthorough
Increasing Productivity and Confidence for N-linked Glycan Analysis of Biosimilars Using the BioAccord System
2019|Waters|Applications
[ APPLICATION NOTE ] Increasing Productivity and Confidence for N-linked Glycan Analysis of Biosimilars Using the BioAccord System Ximo Zhang, Corey Reed, Henry Shion, William Alley, Robert Birdsall, and Ying Qing Yu Waters Corporation, Milford, MA, USA APPLICATION BENEFITS ■■…
Key words
glycan, glycanbioaccord, bioaccordbiosimilars, biosimilarsbiosimilar, biosimilarconfidence, confidencelinked, linkedflr, flrreleased, releasedglycans, glycansproductivity, productivityrda, rdaacquity, acquityinnovator, innovatorsystem, systemanalysis